Your browser doesn't support javascript.
loading
Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.
Braiteh, Fadi; Soriano, Andres O; Garcia-Manero, Guillermo; Hong, David; Johnson, Marcella M; Silva, Leandro De Padua; Yang, Hui; Alexander, Stefanie; Wolff, Johannes; Kurzrock, Razelle.
Affiliation
  • Braiteh F; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine and Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Clin Cancer Res ; 14(19): 6296-301, 2008 Oct 01.
Article in En | MEDLINE | ID: mdl-18829512
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Antineoplastic Combined Chemotherapy Protocols / Valproic Acid / CpG Islands / Epigenesis, Genetic / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Antineoplastic Combined Chemotherapy Protocols / Valproic Acid / CpG Islands / Epigenesis, Genetic / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Type: Article Affiliation country: United States